Studies have also used CD28 with dual CARs, such as HER2/MUC1 bispecific CARs in in-vitro breast cancer models and HER2/IL13Rα2 CARs in xenograft glioma models (86, 87). Here, MUC1 is linked to central nervous system cancer.